This inventor holds 1 USPTO granted patent. Top assignee: Laurus Labs Private Limited. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Nageswara Rao Regandla: Innovator in Pharmaceutical Chemistry
Introduction
Nageswara Rao Regandla is a prominent inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on nilotinib hydrochloride.
Latest Patents
Nageswara Rao Regandla holds a patent for the "Crystalline form of nilotinib hydrochloride, process for its preparation and pharmaceutical composition containing the same." This invention relates to a novel crystalline form of nilotinib hydrochloride, detailing the process for its preparation and the pharmaceutical composition that includes this compound. He has 1 patent to his name.
Career Highlights
Nageswara Rao Regandla is associated with Laurus Labs Private Limited, a company known for its focus on pharmaceutical development and manufacturing. His work at Laurus Labs has positioned him as a key player in the advancement of pharmaceutical innovations.
Collaborations
He has collaborated with notable colleagues such as Ram Thaimattam and Suresh Babu Radhakrishnan, contributing to various projects within the pharmaceutical sector.
Conclusion
Nageswara Rao Regandla's contributions to pharmaceutical chemistry, particularly through his patent on nilotinib hydrochloride, highlight his role as an innovator in the industry. His work continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile